Completed PHASE4 INTERVENTIONAL 1-arm NCT01167452

Effect of Weight and/or Obesity on Sulfamethoxazole and Trimethoprim Concentrations

Population Pharmacokinetic Analysis of Sulfamethoxazole and Trimethoprim in Normal Weight, Overweight, and Obese Volunteers

Sponsor: National Center for Research Resources (NCRR)

Conditions MRSA Obesity PCP Pharmacokinetics Tuberculosis

Interventions Sulfamethoxazole/trimethoprim

Updated 8 times since 2017 Last updated: May 17, 2017 Started: Jul 31, 2010 Primary completion: May 31, 2012 Completion: May 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01167452, this PHASE4 trial focuses on MRSA and Obesity and remains completed. Sponsored by National Center for Research Resources (NCRR), it has been updated 8 times since 2010, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Jan 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Jul 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Center for Research Resources (NCRR)
Texas Tech University Health Sciences Center
University of Texas Southwestern Medical Center

Data source: Texas Tech University Health Sciences Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dallas, United States